Fas Apoptosis Inhibitory Molecule 2 Inhibits Pathological Cardiac Hypertrophy by Regulating the MAPK Signaling Pathway

Background Pathological cardiac hypertrophy stands as a pivotal mechanism contributing to diverse cardiovascular diseases, ultimately leading to heart failure. Despite its clinical significance, the intricate molecular mechanisms instigating pathological cardiac hypertrophy remain inadequately under...

Descripció completa

Dades bibliogràfiques

Autors principals:	Huaping Zhong, Minyu Wu, Heping Xie, Xu Chen, Jiayi Li, Zhisheng Duan, Hong Chen, Ziyou Liu, Wei Liao, Yijian Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2024-11-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	cardiac hypertrophy FAIM2 fibrosis heart failure therapy
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.124.034257
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!